vs
Helmerich & Payne, Inc.（HP）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Helmerich & Payne, Inc.的季度营收约是Royalty Pharma plc的1.6倍（$981.1M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs -9.9%，领先44.3%），Helmerich & Payne, Inc.同比增速更快（45.4% vs 4.8%），过去两年Helmerich & Payne, Inc.的营收复合增速更高（19.7% vs 4.6%）
Helmerich & Payne（简称H&P）是总部位于美国俄克拉荷马州塔尔萨的跨国石油钻探承包商，为油气勘探开发企业提供钻井及相关配套服务。公司1998年推出的FlexRigs系列钻井平台广泛应用于非常规页岩地层钻探作业，是全球最大的陆上钻探服务商之一。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
HP vs RPRX — 直观对比
营收规模更大
HP
是对方的1.6倍
$622.0M
营收增速更快
HP
高出40.7%
4.8%
净利率更高
RPRX
高出44.3%
-9.9%
两年增速更快
HP
近两年复合增速
4.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $981.1M | $622.0M |
| 净利润 | $-96.7M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | -6.1% | 62.4% |
| 净利率 | -9.9% | 34.4% |
| 营收同比 | 45.4% | 4.8% |
| 净利润同比 | -276.6% | 2.9% |
| 每股收益（稀释后） | $-0.98 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HPRPRX
| Q4 25 | $981.1M | $622.0M | ||
| Q3 25 | $953.8M | $609.3M | ||
| Q2 25 | $1.0B | $578.7M | ||
| Q1 25 | $1.0B | $568.2M | ||
| Q4 24 | $674.6M | $593.6M | ||
| Q3 24 | $691.3M | $564.7M | ||
| Q2 24 | $695.1M | $537.3M | ||
| Q1 24 | $685.1M | $568.0M |
净利润HPRPRX
| Q4 25 | $-96.7M | $214.2M | ||
| Q3 25 | $-57.4M | $288.2M | ||
| Q2 25 | $-162.8M | $30.2M | ||
| Q1 25 | $1.7M | $238.3M | ||
| Q4 24 | $54.8M | $208.2M | ||
| Q3 24 | $75.5M | $544.0M | ||
| Q2 24 | $88.7M | $102.0M | ||
| Q1 24 | $84.8M | $4.8M |
营业利润率HPRPRX
| Q4 25 | -6.1% | 62.4% | ||
| Q3 25 | -0.1% | 70.1% | ||
| Q2 25 | -12.4% | 36.3% | ||
| Q1 25 | 4.2% | 94.0% | ||
| Q4 24 | 13.3% | 60.9% | ||
| Q3 24 | 15.4% | — | ||
| Q2 24 | 16.0% | 50.2% | ||
| Q1 24 | 16.1% | -13.0% |
净利率HPRPRX
| Q4 25 | -9.9% | 34.4% | ||
| Q3 25 | -6.0% | 47.3% | ||
| Q2 25 | -15.7% | 5.2% | ||
| Q1 25 | 0.2% | 41.9% | ||
| Q4 24 | 8.1% | 35.1% | ||
| Q3 24 | 10.9% | 96.3% | ||
| Q2 24 | 12.8% | 19.0% | ||
| Q1 24 | 12.4% | 0.8% |
每股收益（稀释后）HPRPRX
| Q4 25 | $-0.98 | $0.49 | ||
| Q3 25 | $-0.57 | $0.67 | ||
| Q2 25 | $-1.64 | $0.07 | ||
| Q1 25 | $0.01 | $0.55 | ||
| Q4 24 | $0.54 | $0.46 | ||
| Q3 24 | $0.77 | $1.21 | ||
| Q2 24 | $0.88 | $0.23 | ||
| Q1 24 | $0.84 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $269.0M | $618.7M |
| 总债务越低越好 | $2.0B | $9.0B |
| 股东权益账面价值 | $2.7B | $9.7B |
| 总资产 | $6.5B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.75× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资HPRPRX
| Q4 25 | $269.0M | $618.7M | ||
| Q3 25 | $218.3M | $938.9M | ||
| Q2 25 | $187.4M | $631.9M | ||
| Q1 25 | $195.6M | $1.1B | ||
| Q4 24 | $526.5M | $929.0M | ||
| Q3 24 | $510.3M | $950.1M | ||
| Q2 24 | $289.7M | $1.8B | ||
| Q1 24 | $277.0M | $843.0M |
总债务HPRPRX
| Q4 25 | $2.0B | $9.0B | ||
| Q3 25 | $2.1B | $8.9B | ||
| Q2 25 | $2.2B | $8.0B | ||
| Q1 25 | $2.2B | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | $1.8B | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益HPRPRX
| Q4 25 | $2.7B | $9.7B | ||
| Q3 25 | $2.8B | $9.6B | ||
| Q2 25 | $2.9B | $9.5B | ||
| Q1 25 | $3.1B | $9.8B | ||
| Q4 24 | $2.9B | $10.3B | ||
| Q3 24 | $2.9B | $10.3B | ||
| Q2 24 | $2.9B | $9.8B | ||
| Q1 24 | $2.8B | $9.9B |
总资产HPRPRX
| Q4 25 | $6.5B | $19.6B | ||
| Q3 25 | $6.7B | $19.3B | ||
| Q2 25 | $6.9B | $18.3B | ||
| Q1 25 | $7.2B | $17.6B | ||
| Q4 24 | $5.8B | $18.2B | ||
| Q3 24 | $5.8B | $18.0B | ||
| Q2 24 | $4.5B | $17.7B | ||
| Q1 24 | $4.4B | $16.1B |
负债/权益比HPRPRX
| Q4 25 | 0.75× | 0.92× | ||
| Q3 25 | 0.73× | 0.93× | ||
| Q2 25 | 0.76× | 0.84× | ||
| Q1 25 | 0.73× | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | 0.61× | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $182.4M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $114.9M | — |
| 自由现金流率自由现金流/营收 | 11.7% | — |
| 资本支出强度资本支出/营收 | 6.9% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $179.6M | — |
8季度趋势，按日历期对齐
经营现金流HPRPRX
| Q4 25 | $182.4M | $827.1M | ||
| Q3 25 | $206.9M | $702.6M | ||
| Q2 25 | $121.6M | $364.0M | ||
| Q1 25 | $56.0M | $596.1M | ||
| Q4 24 | $158.4M | $742.5M | ||
| Q3 24 | $168.8M | $703.6M | ||
| Q2 24 | $197.4M | $658.2M | ||
| Q1 24 | $143.7M | $664.6M |
自由现金流HPRPRX
| Q4 25 | $114.9M | — | ||
| Q3 25 | $142.8M | — | ||
| Q2 25 | $24.6M | — | ||
| Q1 25 | $-102.7M | — | ||
| Q4 24 | $51.9M | — | ||
| Q3 24 | $62.8M | — | ||
| Q2 24 | $63.0M | — | ||
| Q1 24 | $25.4M | — |
自由现金流率HPRPRX
| Q4 25 | 11.7% | — | ||
| Q3 25 | 15.0% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | -10.1% | — | ||
| Q4 24 | 7.7% | — | ||
| Q3 24 | 9.1% | — | ||
| Q2 24 | 9.1% | — | ||
| Q1 24 | 3.7% | — |
资本支出强度HPRPRX
| Q4 25 | 6.9% | — | ||
| Q3 25 | 6.7% | — | ||
| Q2 25 | 9.3% | — | ||
| Q1 25 | 15.7% | — | ||
| Q4 24 | 15.8% | — | ||
| Q3 24 | 15.3% | — | ||
| Q2 24 | 19.3% | — | ||
| Q1 24 | 17.3% | — |
现金转化率HPRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | 33.89× | 2.50× | ||
| Q4 24 | 2.89× | 3.57× | ||
| Q3 24 | 2.24× | 1.29× | ||
| Q2 24 | 2.23× | 6.45× | ||
| Q1 24 | 1.69× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HP
| North America Solutions | $563.6M | 57% |
| International Solutions Segment | $229.3M | 23% |
| Offshore Solutions | $188.3M | 19% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
